Drugs / Intravenous magnesium sulphate
Intravenous magnesium sulphate
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04497766 | Oct 2019 → Sep 2020 | childhood onset asthma | Saima Khatoon | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Intravenous magnesium sulphate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04497766 ↗ |
| Known as | magnesium sulphate | “Magnesium sulphate according to weight will be given intravenously.” NCT04497766 ↗ |
| Known as | MgSO4 | “MgSO4 100mg in 20 ml normal saline will be given via ultrasonic nebulizer over 10 minutes,and PAS score will be assessed at 30,60,120,240,360 minutes” NCT04497766 ↗ |
| Route | Inhaled | “via ultrasonic nebulizer” NCT04497766 ↗ |